February 14, 2020/Neurosciences/Case Study

Intracerebral Hemorrhage Removal with Endoscopic Side-Cutting Aspiration

First reported case expands use of minimally invasive techniques

By Mark Bain, MD, MS; Jianning Shao, BA; and Pablo Recinos, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Case vignette

A 50-year-old woman with no significant past medical history was transferred to our center emergently with a diagnosis of acute left intracerebral hemorrhage (ICH), noted severe right-sided hemiplegia and aphasia and a National Institutes of Health Stroke Scale score of 27.

Head CT showed a 6.3-cm hematoma in the putamen of the left basal ganglia (Figure 1).

axial head CT showing basal ganglia hemorrhage

Figure 1. Axial head CT revealing 56-cc left basal ganglia hemorrhage.
Reprinted with permission from Shao J, Witek A, Borghei-Razavi H, Bain M, Recinos PF. Endoscopic evacuation of intracerebral hematoma utilizing a side-cutting aspiration device. Oper Neurosurg (Hagerstown). 2019 Oct 12 [Epub ahead of print]. ©2019 by the Congress of Neurological Surgeons.

We obtained a CT angiogram (CTA) to rule out vascular lesions as part of our standard preoperative workup at Cleveland Clinic. Though spot sign was not present, CTA revealed a slight expansion of the parenchymal hematoma and intraventricular extension. The team also noted blood in the ipsilateral ventricle.

Advertisement

Given the hematoma’s size, expansion and presence with intraventricular hematoma (IVH), we explored surgical evacuation, opting for an endoscopic, transcortical approach with a side-cutting aspiration device. Using neuronavigation, we inserted a 19-French peel-away sheath with a 15-gauge side-cutting aspiration device handpiece through a 13-mm burr hole with duratomy and a trans-sulcal approach to access the hematoma. We first addressed the clot in the middle, as it was furthest from eloquent areas. We used the aspiration-only setting of the device to move clot away from parenchymal walls, and then used side-cutting aspiration to diminish the hematoma’s size. Next we began continuous irrigation through the endoscope to expand the cavity for better visualization and mobilization of further clot. We used hemostatic agents and continuous irrigation to achieve endoscopic hemostasis during the procedure. The 13-second intraoperative video below shows aspiration and breaking up of a clot during the case.


An immediate postoperative CT demonstrated clear midline recovery with no evidence of mass effect. The patient began physical therapy on postoperative day 2. When she was discharged on postoperative day 10, she was alert, oriented and slowly regaining strength.

At one-month follow up, axial head CT showed complete resolution of brain shift and little evidence of the surgical tract (Figure 2). The patient was ambulatory but experiencing residual expressive aphasia and right-sided weakness. She continues to improve with appropriate therapies.

postoperative axial head CT showing resolution of intracerebral hemorrhage

Figure 2. One-month postoperative axial head CT showing complete resolution of brain shift and little evidence of surgical tract. Reprinted with permission from Shao J, Witek A, Borghei-Razavi H, Bain M, Recinos PF. Endoscopic evacuation of intracerebral hematoma utilizing a side-cutting aspiration device. Oper Neurosurg (Hagerstown). 2019 Oct 12 [Epub ahead of print]. ©2019 by the Congress of Neurological Surgeons.

Targeting a dynamic disease

Traditionally, ICH was considered a monophasic disease with little demonstrated benefit from support care or craniotomy and with medical management as the standard of care. More recently, we’ve come to understand ICH as a biphasic disease, with the second phase of injury from perihematomal inflammation and edema accounting for the delayed neurological deterioration we often see in ICH patients. In this model of the disease, time and volume control are critical.

While trials have shown no benefit from craniotomy, the recent MISTIE III trial found a mortality benefit to ICH removal via minimally invasive surgery (MIS), with other studies corroborating the results. A higher degree of hematoma evacuation correlated with improved outcomes in MISTIE III. In contrast to the days-long procedure in MISTIE, our novel technique in this case achieved immediate near-total evacuation, thus reducing mass effect and secondary injury. When time and volume are of the essence, our technique offers a faster, more complete evacuation.

Advertisement

The device we used is one of many new developments in MIS for ICH evacuation. This side-cutting aspiration device features dual functionalities that permit homogenization and removal of clots, while a blunt end reduces parenchymal injury risk. The surgeon modulates suction strength with a foot pedal. Two ongoing studies — Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH) and Prospective, Multicenter Study of Artemis, a Minimally Invasive Neuro Evacuation Device (MIND) — are exploring other MIS devices and early intervention techniques.

Tips for implementing in your practice

Because our patient’s hematoma was stable, her case offered an ideal scenario for side cutting with an endoscopic approach. We recommend early and immediate evacuation, with a preoperative CTA to assess for the presence of arteriovenous malformations or aneurysms. This imaging is part of our standard of care at Cleveland Clinic and is a required part of many clinical trials in this arena. Our operative setup included monitors showing navigation and endoscopic views side by side to optimize visualization. We also had previous experience in the use of this device for evacuation of intraventricular empyema in four patients. Our full report of this ICH case in Operative Neurosurgery provides additional images and video of the surgical technique.

Our experience in this case offers a modification to the stereotactic intracerebral hemorrhage underwater blood aspiration (SCUBA) technique: the first documented use of a side-cutting aspiration device via an endoscopic transcortical approach for evacuation of ICH. While more study is needed, we hope our experience with this patient contributes to efforts to develop a standardized endoscopic approach to treatment of ICH.

Dr. Bain is Head of Cerebrovascular and Endovascular Neurosurgery in Cleveland Clinic’s Cerebrovascular Center. Ms. Shao is a medical student at Cleveland Clinic Lerner College of Medicine. Dr. Recinos is a neurosurgeon at Cleveland Clinic with specialty expertise in skull base surgery.

Related Articles

22-NEU-3038364-CQD-Hero-650×450
September 8, 2022/Neurosciences/Case Study
Case Study: Rare Cerebrovascular Condition in a Postpartum Patient

When specialized surgery makes sense for moyamoya syndrome

22-NEU-3097423-CQD-Hero-650×450
August 19, 2022/Neurosciences/Case Study
Cervical Kyphosis in a Geriatric Patient: A Case Study

Multilevel cervical fusion restores function in an athletic 78-year-old

22-NEU-2918752-CQD-Hero-650×450 (1)
Laser Ablation for Unilateral Periventricular Nodular Heterotopia and Drug-Resistant Epilepsy

Case study underscores the imperative for thorough evaluation with SEEG

21-NEU-2051980 schwannoma of lacrimal nerve_650x450
April 22, 2021/Neurosciences/Case Study
Case Study: A Tumor in the No-Man’s-Land Between Eye, Nose and Brain

Schwannoma of the lacrimal nerve threatened right eye blindness

MRI showing a spinal ependymoma
Case Study: 46-Year-Old With Invasive Anaplastic Grade III Spinal Ependymoma

Partial resection plus radiation leads to good outcome from an unpredictable tumor

20-NEU-1875736_vertebral-artery-stenosis_650x450
April 28, 2020/Neurosciences/Case Study
Head-Turning Mystery Proves No Match for Dynamic Angiography

Diagnosis and treatment of rotational vertebrobasilar insufficiency syndrome

Hero.650×450
November 21, 2019/Neurosciences/Case Study
Challenges of Epilepsy Surgery in an Infant with a Hemispheric Syndrome: Case Study

Much is possible when treating epilepsy in the developing brain

Ad